ÈÀåÇ° ¼ººÐ ¿¬±¸ |
1 | ¿ä¾à¼³¸í | ³ªÀ̾ƽ󪸶ÀÌµå ´Â ºñŸ¹Î B3(³ªÀ̾ƽÅ)ÀÇ ¼ö¿ë¼º À¯µµÃ¼ÀÔ´Ï´Ù. ½Ä¾àó¿¡ °í½ÃµÈ ¹Ì¹é ±â´É¼º ¼ººÐÀ¸·Î ÈÀåÇ° (¹èÇÕ ÇÔ·® 2~5%) ¸á¶ó´Ñ¼¼Æ÷ÀÇ ¸á¶ó³ëÁ»ÀÌ °¢Áú¼¼Æ÷·Î À̵¿À» ¾ïÁ¦ÇÏ¿© ¹Ì¹éÈ¿°ú¸¦ ÁÝ´Ï´Ù. |
||
2 | INCI | Niacinamide | ||
3 | ÇѱÛÀü¼ººÐ¸í | |||
4 | µ¿ÀǾî | ´ÏÄÚƾ¾Æ¸¶À̵å | ||
5 | ¹°¸®ÈÇÐÀû Ư¡ | ÈÇÐ½Ä | ||
±¸Á¶½Ä |
|
|||
ºÐÀÚ·® | 122.12 g/mol | |||
½Ç¿ÂÇü»ó | ||||
²ú´ÂÁ¡ | 157 ¡ÆC | |||
³ì´ÂÁ¡ | 130 ¡ÆC | |||
¿ë¸Å | ||||
6 | ¿ø·á Á¤º¸ | ¿ø·á °ø±Þ»ç | 130 ¡ÆC | |
kg´ç °¡°Ý | 8,000~15,000¿ø | |||
ÁÖ»ç¿ë ³óµµ | 2-5% | |||
100g Á¦Ç°´ç ¼ººÐ°¡°Ý | 16¿ø | |||
7 | »ý»ê ¹æ½Ä | ÇìÅ׷λçÀÌŬ¸¯ ¹æÇâÁ· ¾Æ¸¶À̵å | ||
8 | ¼ººÐ¿¡ ´ëÇÑ ¿ª»ç | Niacinamide´Â ºñŸ¹Î B3ÀÇ À¯µµÃ¼·Î, ¼¼Æ÷ÀÇ ´ë»ç È°µ¿¿¡ ÇÊ¿äÇÑ ¿¡³ÊÁö È帧¿¡ °ü¿©ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ¾ú½À´Ï´Ù. 1970³â´ë¿¡ Girish Prasad Mathur´Â Niacinamide°¡ ÇǺΠÅæÀ» ¹à°Ô Çϴµ¥¿¡ ¸Å¿ì È¿°úÀûÀÓÀ» ¾Ë¾Æ³», ÈÀåÇ°¿¡ óÀ½ µµÀÔÇÏ¿© ƯÇã Ãâ¿ø. 2002³â Hakozaki ¿¬±¸ÁøµéÀº ³ªÀ̾ƽžƸ¶À̵尡 ÈæÀÚ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» 8ÁÖ°£ °üÂûÇÑ °á°ú, À¯ÀǹÌÇÑ spot °¨¼Ò È¿°ú °ËÁõ. |
||
9 | È¿´É | °æ±¸º¹¿ëÈ¿´É | Æç¶ó±×¶ó Ä¡·áÁ¦. Æç¶ó±×¶ó Áõ»ó 3D dermatitis, diarrhea, dementia | |
±¹¼ÒµµÆ÷ È¿´É | 1. ¹Ì¹é È¿°ú : ÀÏÁ¤·® ÀÌ»ó µµÆ÷ ½Ã, melanocyte¿¡¼ Çü¼ºµÈ melanosomeÀÌ ±ÙóÀÇ keratinocyte·Î À̵¿µÇ´Â °ÍÀ» ¸·¾ÆÁÜÀ¸·Î½á, ÇǺο¡ »ö¼Ò ħÂøÀÌ µÇ´Â °ÍÀ» ¾ïÁ¦ÇØÁØ´Ù. 2. À庮 °³¼± È¿°ú : TEWL °¨¼Ò, ÇǺΠ¼öºÐ ÇÔÀ¯ °³¼±, ¼¼¶ó¸¶À̵å ÇÕ¼º¿¡ µµ¿òÀ» ÁÖ¾î, ÇǺο¡ ÀÚ±ØÀ» ÁÖ´Â ¿äÀε鿡 ´ëÇÑ ÀúÇ×¼ºÀ» °¡Áöµµ·Ï µµ¿ÍÁÜ. 3. Ç׿° È¿°ú 4. Ç×ÁÖ¸§ È¿°ú : Äݶó°Õ, ÄɶóƾÀÇ ÇÕ¼ºÀ» ÃËÁø½ÃÅ´ 5. ÇÇÁö °¨¼ÒÈ¿°ú |
|||
10 | ÈÀåÇ°³» ±â´É
ÁÖ±â´É¡Ü ºÎ±â´É¡Û |
¿ëÁ¦ | ||
°è¸éÈ°¼ºÁ¦ | ||||
¹ß¸²¼ºÁ¦ | ||||
Á¡ÁõÁ¦ | ||||
pHÁ¶ÀýÁ¦ | ||||
ų·¹ÀÌÆÃÁ¦ | ||||
Çâ | ||||
¹æºÎÁ¦ | ||||
È¿´É¼ººÐ µî | ¡Ü | |||
11 |
È¿´É¼ººÐ (DOSPAW-O) ÁÖÈ¿´É¡Ü ºÎÈ¿´É¡Û |
DRY º¸½ÀÁ¦ |
À庮°³¼±Á¦ | ¡Û |
ÇÔ½ÀÁ¦ | ||||
¹ÐÆóÁ¦ | ||||
OILY Ç׿ÀÀÏÁ¦ |
ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (5a-reductase inhibitor ¾ïÁ¦Á¦) | ¡Ü | ||
ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (ÇÇÁö¼± ¼¼Æ÷ »ç¸êÁ¦) | ||||
ÇÇÁöÈíÂøÁ¦ | ||||
°¢ÁúÁ¦°ÅÁ¦ | ||||
SENSITIVE Ç׿°Á¦ |
NFkB ¾ïÁ¦Á¦ | ¡Ü | ||
phospholipase ¾ïÁ¦Á¦ | ||||
Cycloxygenase ¾ïÁ¦Á¦ | ||||
À庮°³¼±Á¦ | ¡Û | |||
PIGMENT »ö¼Ò¾ïÁ¦Á¦ |
tyrosinase ¾ïÁ¦Á¦ | |||
¸á¶ó´Ñ À̵¿ ¾ïÁ¦Á¦ | ¡Ü | |||
°¢ÁúÁ¦°ÅÁ¦ | ||||
ACNE ¿©µå¸§¾ïÁ¦Á¦ |
ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (5a-reductase inhibitor ¾ïÁ¦Á¦) | ¡Û | ||
ÇÇÁöºÐºñ ¾ïÁ¦Á¦ (ÇÇÁö¼± ¼¼Æ÷ »ç¸êÁ¦) | ||||
°¢ÁúÁ¦°ÅÁ¦ | ||||
Ç×±ÕÁ¦(MIC) | ||||
Ç׿°Á¦ | ¡Ü | |||
WRINKLE ÁÖ¸§¾ïÁ¦Á¦ (Ç¥ÇÇ) |
Ç¥ÇǼ¼Æ÷Áõ½ÄÁ¦ | ¡Ü | ||
Ç¥ÇǼ¼Æ÷ºÐÈÁ¦ | ||||
À庮±â´É°³¼±Á¦ | ¡Û | |||
WRINKLE ÁÖ¸§¾ïÁ¦Á¦ (ÁøÇÇ) |
¼¶À¯¾Æ¼¼Æ÷Áõ½ÄÁ¦ | |||
Äݶó°Õ¼¶À¯»ý¼ºÁ¦ | ||||
ź·Â¼¶À¯»ý¼ºÁ¦ | ||||
GAGs»ý¼ºÁõ°¡Á¦ | ||||
Äݶó°Õ¼¶À¯ºÐÇØ°¨¼ÒÁ¦ | ||||
OXIDANT Ç×»êÈÁ¦ |
Ç×»êÈÁ¦ | ¡Û | ||
12 | ¿ÏÁ¦Ç° Á¤º¸ | ÁÖ¿ä ÇÔÀ¯ Á¦Ç° | ºê·£µå¸í: ´ÚÅÍÀÚ¸£Æ® Á¦Ç°¸í: V7 ÇÎÅ© Åä´× 50ml/ 48,000¿ø |
|
´ÚÅÍ¿À¶óŬ Á¦Ç° | ºê·£µå¸í: ´ÚÅÍ¿À¶óŬ Á¦Ç°¸í: ¸®¾óÈÀÌÆ® ¸ðÀ̽ºÆ® Á©¸® ºÎ½ºÅÍ 120ml / 42,000¿ø |
|||
13 | °á·Ð | ³ªÀ̾ƽžƸ¶À̵å´Â ÇǺΠ±âÀúÃþ¿¡¼ÀÇ »ö¼Ò À̵¿À» ¾ïÁ¦ÇØÁÖ´Â ¹Ì¹é ±â´É¼º °í½Ã¼ººÐÀ¸·Î ³Î¸® ¾Ë·ÁÁ®ÀÖ´Ù. ÁöÁú ÇÕ¼ºÀ» µµ¿Í ÇǺΠÀ庮 ±â´ÉÀ» °ÈÇØÁÖ°í, ÁÖ¸§ ¿¹¹æ¿¡µµ µµ¿òÀÌ µÇ¸ç, ÇÇÁö ºÐºñ °¨¼Ò ¹× Ç׿°È¿°ú¸¦ ÅëÇØ ¿©µå¸§ Áõ»ó °³¼±¿¡µµ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Ù. Áï ¹Ì¹éÈ¿°ú ÀÌ¿Ü¿¡µµ º¸½À, Ç׿°, Àç»ý, Ç׿©µå¸§ È¿°ú°¡ ÀÖ´Ù. |
||
14 | Àοë³í¹® | 1. Bender 2003. Nutritional Biochemistry of the Vitamins. Cambridge University Press. p. 203. ISBN 978-1-139-43773-8. Archived from the original on 2016-12-30. 2. Berge et al. 2006. Niacinamide-Containing Facial Moisturizer Improves Skin Barrier and Benefits Subjects with Rosacea. Therapeutics for the Clinician. Retrieved from (https://pdfs.semanticscholar.org/c866/417320abb8a6d79791d10ad66c6acc6b22d2.pdf) 3. Bissett, D. L., Oblong, J. E., & Berge, C. A. (2005). Niacinamide: AB vitamin that improves aging facial skin appearance. Dermatologic surgery, 31, 860-866. 4. British National Formulary: BNF 69 (69th ed.). British Medical Association. 2015. p. 822. ISBN 978-0-85711-156-2. 5. Decker et al. 2012. Over-the-counter acne treatments: a review. The Journal of clinical and aesthetic dermatology, 5(5), 32. Retreived from (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366450/pdf/jcad_5_5_32.pdf) 6. Esfahani, Soheil Ashkani, et al. "Topical nicotinamide improves tissue regeneration in excisional full-thickness skin wounds: A stereological and pathological study." Trauma monthly 20.4 (2015). 7. Gehring 2004. Nicotinic acid/niacinamide and the skin. Journal of Cosmetic Dermatology. Retrieved from (https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1473-2130.2004.00115.x)" 8. Hakozaki et al. 2002. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. Retrieved from (https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2133.2002.04834.x) 9. Jacobson, et al. 2007. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Experimental dermatology, 16(6), 490-499. 10. Kenneth S. et al. 2006. The effect of 2% niacinamide on facial sebum production. Journal of Cosmetic and Laser Therapy. Retrieved from (https://www.tandfonline.com/doi/abs/10.1080/14764170600717704) 11. Kimball et al. 2010. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N‐acetyl glucosamine: results of a randomized, double‐blind, vehicle‐controlled trial. British Journal of Dermatology. Retrieved from (https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2133.2009.09477.x) 12. Who Model Formulary 2008. World Health Organization. 2009. pp 496, 500. ISBN 978-924-154765-9. Archived from the original on December 13, 2016. Retrieved December 8, 2016. 13. Wohlrab et al. 2014. Niacinamide-mechanisms of action and its topical use in dermatology. Skin pharmacology and physiology, 27(6), 311-315. |